Telehealth platforms can make GLP-1 medications more accessible and sometimes cheaper — but the answer depends heavily on your insurance, whether you use a brand-name or compounded drug, and which platform you choose. In some cases, online prescribers save you money; in others, you pay more than you would through a traditional doctor visit covered by insurance.
What Do Brand-Name GLP-1 Medications Actually Cost?
Without insurance, brand-name GLP-1 drugs carry some of the highest list prices in the pharmacy. According to GoodRx data from 2024, approximate monthly retail prices are:
- Ozempic (semaglutide, 0.5–2 mg): ~$935–$970 per month
- Wegovy (semaglutide, 2.4 mg): ~$1,349 per month
- Mounjaro (tirzepatide, 2.5–15 mg): ~$1,023–$1,069 per month
- Zepbound (tirzepatide, 2.5–15 mg): ~$1,059–$1,086 per month
These prices apply whether you get a prescription from your primary care doctor, an endocrinologist, or a telehealth platform. The drug itself costs the same at the pharmacy — what varies is how you access the prescription and what additional fees are involved.
How Does Telehealth Change the Cost Picture?
Telehealth platforms like Hims & Hers, Ro, Calibrate, and Found typically charge a monthly membership or consultation fee — often ranging from $20 to $99 per month — in exchange for an online evaluation, a prescription, and ongoing check-ins. That fee replaces a traditional office copay, which for specialist visits can run $50–$250 or more without insurance.
Where telehealth can genuinely save money is in three scenarios:
- You have no insurance or poor coverage. A telehealth visit may cost less than an uninsured in-person appointment, reducing your total out-of-pocket spend even if the drug price is the same.
- The platform offers compounded semaglutide or tirzepatide. Some telehealth services prescribe compounded versions (see below) at dramatically lower prices — often $150–$400 per month.
- The platform helps you apply manufacturer savings cards. Novo Nordisk and Eli Lilly both offer savings programs (e.g., Novo Nordisk's Ozempic Savings Card) that can reduce costs to as low as $25/month for eligible commercially insured patients. Many telehealth services assist with enrollment.
Most important point: The biggest cost variable is not the telehealth platform — it's whether your insurance covers GLP-1 medications. If your plan covers Wegovy or Zepbound, filling through a traditional in-network provider will almost always be cheaper than paying out-of-pocket through any telehealth service.
What About Compounded GLP-1 Medications Online?
During the FDA-declared shortage of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), which began in 2022, FDA regulations temporarily allowed state-licensed compounding pharmacies to produce copies of these drugs. Many telehealth platforms seized on this, offering compounded semaglutide or tirzepatide injections for $150–$400 per month — a fraction of brand-name costs.
However, there are important caveats the FDA has flagged:
- Compounded drugs are not FDA-approved. They have not been evaluated for safety, efficacy, or quality in the same way as brand-name products (FDA, Compounding Q&A).
- In early 2025, the FDA removed semaglutide and tirzepatide from the shortage list, meaning compounding pharmacies can no longer legally produce copies of these drugs for most patients under shortage-based exemptions. Enforcement timelines are ongoing — check current FDA guidance for the latest status.
- Some compounded versions have used salt forms (e.g., semaglutide sodium or acetate) not used in FDA-approved products, raising additional safety questions.
If a telehealth platform is still advertising compounded GLP-1s at steep discounts, verify its current legal standing carefully before ordering.
How Do Costs Compare Across Pathways? A Side-by-Side Look
| Access Pathway | Consultation Cost | Drug Cost (Monthly) | Best For |
|---|---|---|---|
| In-person doctor + insurance covering GLP-1 | Copay (~$20–$60) | Copay or ~$25 with savings card | Insured patients with GLP-1 coverage |
| In-person doctor, no insurance | $100–$300+ | $935–$1,349 retail | Not cost-effective without a savings card |
| Telehealth platform + insurance | $20–$99/month membership | Copay or ~$25 with savings card | Insured patients who prefer convenience |
| Telehealth platform, no insurance, brand-name | $20–$99/month membership | $935–$1,349 retail | Only cost-effective with manufacturer savings card |
| Telehealth + compounded GLP-1 (where legal) | Included or ~$20–$50 | $150–$400 | Uninsured; carries regulatory and quality risks |
Are There Hidden Costs With Telehealth GLP-1 Services?
Telehealth platforms market themselves on convenience and price, but watch for costs that aren't always front-and-center:
- Ongoing membership fees: Some platforms charge monthly fees even during months when you only need a refill, not a new evaluation.
- Bundled coaching programs: Services like Calibrate bundle lifestyle coaching with the prescription, which raises the monthly total significantly.
- Separate pharmacy fees: Some platforms send prescriptions to their own affiliated pharmacies, which may charge differently than your local chain pharmacy or mail-order service.
- Lab work: Responsible prescribers — online or in person — typically require baseline labs (HbA1c, kidney function, etc.) before starting. These may or may not be covered by your insurance.
- Dose escalation supply gaps: Telehealth platforms may not always have every dose strength available, which matters as you titrate up per the dosing schedule in FDA labeling.
Frequently Asked Questions
Cost is one of the biggest barriers to GLP-1 treatment, and telehealth can genuinely help some patients — especially those without insurance — access these medications more affordably and conveniently. But the cheapest option isn't always the safest or the most effective long-term. Before enrolling in any online GLP-1 program, talk with your prescriber or a licensed clinician who can review your health history, confirm you're a good candidate based on FDA-approved criteria, and set up appropriate monitoring throughout your treatment.
- FDA. 'Compounded Drugs.' FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- FDA. 'FDA Alerts Patients and Health Care Professionals of the Agency's Semaglutide Shortage Update.' FDA.gov. 2024.
- Wilding JPH, et al. 'Once-Weekly Semaglutide in Adults with Overweight or Obesity.' NEJM. 2021. DOI: 10.1056/NEJMoa2032183
- Jastreboff AM, et al. 'Tirzepatide Once Weekly for the Treatment of Obesity.' NEJM. 2022. DOI: 10.1056/NEJMoa2206038
- GoodRx. 'Ozempic Prices, Coupons & Savings Tips.' GoodRx.com. 2024.
- Novo Nordisk. 'Ozempic U.S. Prescribing Information.' FDA.gov.
- Eli Lilly. 'Mounjaro U.S. Prescribing Information.' FDA.gov.
- KFF Health News. 'Telehealth Prescribing of Weight-Loss Drugs.' 2024.